Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
34,778
datasets available to search
ShareScore release 0.9.0
Dataset results
34,778 results for “Diseases”
Figure 5 in Reproductive diseases in captive Agoutis (Dasyprocta leporina)
Figure 5. Vaginal prolapse inserted into the pelvic cavity postoperatively.
Figure 1 in Prevalence of intestinal parasitic diseases in school children of rural areas of district Lower Dir, Pakistan
Figure 1. Parts of the region studied.
Figure 1 in Detection of respiratory viruses and expression of inflammatory cytokines in patients with acute exacerbation chronic obstructive pulmonary disease in Mongolia China
Figure 1. Distribution of Viruses.
Spatial transcriptomics defines injury specific microenvironments and cellular interactions in kidney regeneration and disease
<p>This dataset contains raw and processed seqFISH data quantifying 1300 genes within single cells from three Acute Kidney Injury (AKI) and three control mice kidneys. The dataset also contains the codebook and probe sequences used to create probe libraries for the seqFISH experiments.</p> <p><strong>Supplementary_data_tables</strong> folder contains the supplementary data tables for the manuscript: Data_1 contains DE gene expression, Data_2 and Data_3 contain the codebook and probe sequence information needed to generate the probe libraries used for the seqFISH experiments. Data_4 contains the probe sequence information needed to generate the serial probes against <em>Vcam1</em> and <em>Havcr1</em></p> <p><strong>AKI_Ctrl_object.rds</strong> - Seurat object generated from seqFISH data for the AKI and healthy control mice as detailed in the manuscript.</p> <p><strong>Counts_raw.csv </strong>contains raw gene counts for all cells in the dataset.</p> <p><strong>coordinates.csv</strong> contains the xy coordinates (in um) for every cell in the dataset.</p> <p><strong>metadata.csv</strong> contains the metadata for each cell in the dataset including sample and cell type allocation as well as Microenvironment (ME) assignment. This file also contains expression data of <em>Vcam1</em> and <em>Havcr1, </em>which were detected using serial probes as detailed in the manuscript.</p>
Spatial transcriptomics defines injury specific microenvironments and cellular interactions in kidney regeneration and disease
<p>Kidney injury disrupts the intricate renal architecture and triggers limited regeneration, and injury-invoked inflammation and fibrosis. Deciphering molecular pathways and cellular interactions driving these processes is challenging due to the complex renal architecture. Here, we apply single cell spatial transcriptomics to examine ischemia-reperfusion injury in the mouse kidney. Spatial transcriptomics reveals injury-specific and spatially-dependent gene expression patterns in distinct cellular microenvironments within the kidney and predicts <em>Clcf1-Crfl1</em> in a molecular interplay between persistently injured proximal tubule cells and neighboring fibroblasts. Immune cell types play a critical role in organ repair. Spatial analysis reveals cellular microenvironments resembling early tertiary lymphoid structures and identifies associated molecular pathways. Collectively, this study supports a focus on molecular interactions in cellular microenvironments to enhance understanding of injury, repair and disease.</p>
Interviews for New Business Models for Pharmaceutical Innovation and Access to Medicines - Neglected Diseases
<p>These supplementary materials represent the partial dataset in the form of semi-structured interviews, collected and analyzed in the research article "Alternative pharmaceutical innovation models for neglected diseases: How can they continue to thrive?". This article is one of the outcomes of the "New Business Models for Pharmaceutical Innovation and Global Access to Medicines" research project, conducted at the Global Health Center, within the Geneva Graduate Institute. The dataset contains 8/21 interviews collected and used in this article, which are published with the informed consent of the interviewees.</p> <p>Details about the research project can be found at: <a href="https://www.graduateinstitute.ch/NBM">https://www.graduateinstitute.ch/NBM</a></p>
single-nucleus RNA sequencing data of Minimal Change Disease and Focal Segmental Glomerulosclerosis patients
<p>single-nucleus RNA sequencing data of Minimal Change Disease and Focal Segmental Glomerulosclerosis patients</p>
Fig. 4 in Debilitating disease in a polyparasitised woylie (Bettongia penicillata): A diagnostic investigation
Fig. 4. Frontal view of the head of the woylie, showing thickened and inflamed lip margins.
Modeling Lewy Body Disease with SNCA Triplication iPSC-Derived Cortical Organoids and Identifying Therapeutic Drugs
<p><span>This repository contains the source code for the single-cell and single-nuclei RNA sequencing data analysis for the study <strong><span>Modeling Lewy Body Disease with SNCA Triplication iPSC-Derived Cortical Organoids and Identifying Therapeutic Drugs</span></strong> by Yunjung Jin et al.<br></span></p>
Data from a field plot experiment with the canola pathogen Leptosphaeria maculans including disease severity at the leaf spot and canker stages of the epidemic, and population composition as isolates infectivity pathotypes.
<p><strong>Data set</strong></p> <p>Data are from an experiment simulating how differences in <em>Brassica napus</em> resistance deployment strategies and landscape connectivity influence epidemic severity and pathogen population composition of the fungus <em>Leptosphaeria maculans</em> on field plots inoculated with combinations of stubble in 2016 at CSIRO Canberra, ACT, Australia. Disease severity was assessed on the 60 field plots [Data_severity.csv] and 1490 isolates were sampled and assessed for infectivity [Data_infectivity.csv]. This dataset is described and analyzed in Bousset et al. (2018).</p> <p>Treatments were factorial combination of Resistance, Genetic Connectivity and Spatial Connectivity, replicated in 4 blocks (B1 to B4). Resistance has 3 categories (Rlm4, Rlm6 LepR1) differing by the resistance genes in oilseed rape varieties. Genetic Connectivity has 2 levels (HighGC, LowGC) differing by the pre-adaptation of the stubble populations to the host variety. Spatial Connectivity has two levels (HighSC, LowSC) differing by the stubble load. Control plots had NoStubble.</p> <p><strong>Data files</strong></p> <p>[Data_severity.csv] Disease severity was assessed on the 60 field plots at leaf spot and canker stages of the epidemic. Leaf spots data are counts. Canker data are numbers of stems in 12 categories defined by the cankered area on cross section (0 = no canker to 100 = fully cankered).</p> <p>[Data_infectivity.csv] Two types of isolates (122 from 3 stubble sources with contrasting preadaptation and 1368 from leaves sampled on 50 field plots) were tested for infectivity response (V = infective; A = non-infective) on the three host varieties (Rlm4, Rlm6 LepR1), at the seedling stage in greenhouse.</p> <p><strong>Associated publication</strong></p> <p>Bousset L, Sprague S, Thrall PH, Barrett LG (2018). Spatio-temporal connectivity and host resistance influence evolutionary and epidemiological dynamics of the canola pathogen <em>Leptosphaeria maculans. Evolutionary Applications</em> [ DOI: 10.1111/eva.12630 ].</p> <p><strong>Funding information</strong></p> <p>This work benefited from the financial support of INRA – the French National Institute for Agronomical Research, a CSIRO Sir Frederick McMaster fellowship to L. Bousset (Impact of inoculum carry-over on landscape dynamics of the blackleg canola pathogen) and the Grains Research & Development Corporation (GRDC Grant CSP00192)</p>
CancerEpiSys – Integrative analysis of epigenetic networks that determine the chronic lymphocytic leukemia disease state
<p>A public repository of data processed for Mallm, Iskar, Ishaque et. al. 2018 Linking aberrant chromatin features in chronic lymphocytic leukemia to deregulated transcription factor networks</p> <p><strong>Website:</strong> http://www.cancerepisys.org/cancerepisys/index.html</p> <p><strong>Github:</strong> https://github.com/CancerEpiSys/Mallm-et-al-processing-scripts</p> <p><strong>Research mission</strong></p> <p><em>CancerEpiSys</em> is a BMBF funded research project with the <a href="http://www.bmbf.de/foerderungen/15063.php">CancerSys program</a> that dissects the epigenetic networks associated with chronic lymphocytic leukemia (CLL) to develop novel diagnostic and therapeutic approaches for the disease. It has been initiated based on the emerging view that signals encoded in the DNA sequence, epigenetic modifications (e.g. DNA methylation, post-translational histone modifications), non-coding RNAs and nucleosome positioning are not independently regulated properties. Rather, these chromatin features are governed by an interconnected network of molecular processes that determine the cellular gene expression program. Any errors that occur in the interplay of these factors can lead to aberrant gene regulation associated with cancer. To rationalize the mode of action of novel ‘epigenetic’ drugs in cancer therapy that change properties of this network, we will dissect experimentally and mathematically the interdependence of these processes, focusing on CLL.</p> <p>The main objectives of <em>CancerEpiSys</em> are: (i) deciphering the relation of DNA sequence, epigenetic modifications, nucleosome positioning and aberrant gene expression in CLL, (ii) the identification of epigenetic network morphologies that describe the response to the epigenetic drugs panobinostat and 3-deazaneplanocin (DZNep) that inhibit histone deacetylases and methyltransferases, (iii) the characterization of epigenetic markers and chromatin features of CLL patient subgroups, and (iv) the integration of results into an analysis scheme for the epigenetic aberrations most relevant for prognostication, prediction of treatment relapse and stratification of patients with respect to therapeutic options. Moreover, our results will inform novel therapeutic approaches that target gene-expression programs at the epigenetic level to sensitize cancer cells towards apoptosis and anti-growth signals.</p>
Noscapine treatment effect in transgenic mouse model of Alzheimer's disease
<p>Cerebrovascular dysfunction and neuroinflammation play key roles in the pathophysiology of Alzheimer’s disease (AD). The kinin-kallikrein system involving bradykinin receptor has been proposed at the nexus of beta-amyloid, vascular pathology and inflammation in patients with AD and in animal models. Here, we evaluated the effect of blocking the bradykinin receptors 1 and 2 by treatment with the bradykinin antagonist noscapine on cerebrovascular dysfunction, inflammation and amyloid pathology in a transgenic mouse model of amyloidosis. Transgenic arcAβ mice, and wild-type littermates of 14 months-of-age were either treated with noscapine (3 g/L, acidified drinking water) or received drinking water as control for three months (n = 8-11 per group). Arterial spin labeling magnetic resonance imaging showed alleviated regional hypoperfusion in noscapine-treated arcAb compared to control arcAb mice. Functional magnetic resonance imaging showed mitigated reduced regional cerebral vascular reactivity in noscapine-treated arcAb compared to control arcAb mice.</p>
Investigating Temperature Tolerance in Mosquito Disease Vectors Across a Land-Use Gradient
<b>Description: </b><p>Mosquito larval survey and thermotolerance data</p><p><b>Project: </b>This dataset was collected as part of the following SAFE research project: <a href="https://www.safeproject.net/projects/project_view/172"><b>Investigating Temperature Tolerance in Mosquito Disease Vectors Across a Land-Use Gradient</b></a></p><p><b>XML metadata: </b>GEMINI compliant metadata for this dataset is available <a href="https://www.safeproject.net/datasets/xml_metadata?id=82">here</a></p><p><b>Data worksheets: </b>There are 4 data worksheets in this dataset:</p><ol><li><p><b>Field microclimate data</b> (Worksheet Microclimate)</p><p>Dimensions: 6917 rows by 11 columns</p><p>Description: Data was recorded using EasyLog USB dataloggers. They were put out either hung on a tree, or suspended off the ground (in the absense of trees) and covered to avoid direct sunlight.</p><p>Fields: </p><ul><li><b>Block</b>: SAFE Project sampling block (Field type: Location)</li><li><b>Plot</b>: Sample site (Field type: Location)</li><li><b>Site</b>: SAFE Project sampling block (Field type: ID)</li><li><b>Point</b>: SAFE Project sample location (Field type: ID)</li><li><b>DATE</b>: Date of the measurement (Field type: Date)</li><li><b>TIME</b>: Time of the measurement (Field type: Time)</li><li><b>Temp</b>: Air temperature (Field type: Numeric)</li><li><b>RelHumid</b>: Relative humidity (Field type: Numeric)</li><li><b>DewPoint</b>: The temperature at which the air would condense and dew would form (Field type: Numeric)</li><li><b>SerialNumber</b>: Serial number of the microclimate datalogger used to collect the data (Field type: ID)</li></ul><br></li><li><p><b>Thermal tolerance</b> (Worksheet CTmax)</p><p>Dimensions: 317 rows by 6 columns</p><p>Description: Thermal tolerance experiments on mosquito larvae</p><p>Fields: </p><ul><li><b>Date</b>: The Date the CT max value was taken (Field type: Date)</li><li><b>VialNumber</b>: the vial that the individual came from, and how it is referred to in my field notebook (Field type: ID)</li><li><b>LandType</b>: Habitat type from which the individual was collected (Field type: Categorical)</li><li><b>CriticalMax</b>: The temperature in celcius that the individual became unresponsive to stimulus (Field type: Numeric)</li><li><b>GivenSpecies</b>: Identity of the individual being tested (Field type: Taxa)</li></ul><br></li><li><p><b>Site x species data</b> (Worksheet SpeciesData)</p><p>Dimensions: 192 rows by 9 columns</p><p>Description: Field observations of field mosquito communities</p><p>Fields: </p><ul><li><b>Block</b>: SAFE Project sampling block (Field type: Location)</li><li><b>Plot</b>: Sample site (Field type: Location)</li><li><b>Site</b>: SAFE Project sampling block (Field type: ID)</li><li><b>Point</b>: SAFE Project sample site (Field type: ID)</li><li><b>Replicate</b>: is the replicate of sampling each data collection took place. There were three weeks of sampling so the only values are 1, 2, or 3. (Field type: Replicate)</li><li><b>CollectionType</b>: Method of collection (Field type: Categorical)</li><li><b>Count</b>: Total number of individuals sampled (Field type: Abundance)</li><li><b>GivenSpecies</b>: Identity of the individual(s) (Field type: Taxa)</li></ul><br></li><li><p><b>Forest canopy measurements</b> (Worksheet Densiometer)</p><p>Dimensions: 36 rows by 12 columns</p><p>Description: Densiometer estimates of tree canopy cover</p><p>Fields: </p><ul><li><b>Block</b>: SAFE Project sampling block (Field type: Location)</li><li><b>Plot</b>: Sample site (Field type: Location)</li><li><b>Site</b>: SAFE Project sampling block (Field type: ID)</li><li><b>Point</b>: SAFE Project sample site (Field type: ID)</li><li><b>Val1</b>: Number of quartersquares that lack canopy cover in one of the four cardinal directions. The maximum value is 96 if there is no canopy cover. (Field type: Numeric)</li><li><b>Val2</b>: Number of quartersquares that lack canopy cover in one of the four cardinal directions. The maximum value is 96 if there is no canopy cover. (Field type: Numeric)</li><li><b>Val3</b>: Number of quartersquares that lack canopy cover in one of the four cardinal directions. The maximum value is 96 if there is no canopy cover. (Field type: Numeric)</li><li><b>Val4</b>: Number of quartersquares that lack canopy cover in one of the four cardinal directions. The maximum value is 96 if there is no canopy cover. (Field type: Numeric)</li><li><b>AveVal</b>: Average densiometer reading (max = 96) (Field type: Numeric)</li><li><b>AdjustedVal</b>: Average canopy openness (Field type: Numeric)</li><li><b>CanopyCover</b>: Average canopy cover (Field type: Numeric)</li></ul><br></li></ol><p><b>Date range: </b>2017-03-20 to 2017-09-04</p><p><b>Latitudinal extent: </b>4.6314 to 4.7436</p><p><b>Longitudinal extent: </b>117.4556 to 117.6249</p><p><b>Taxonomic coverage: </b><br> All taxon names are validated against the GBIF backbone taxonomy. If a dataset uses a synonym, the accepted usage is shown followed by the dataset usage in brackets. Taxa that cannot be validated, including new species and other unknown taxa, morphospecies, functional groups and taxonomic levels not used in the GBIF backbone are shown in square brackets.</p><div>Animalia<br> - Arthropoda<br> -  - Insecta<br> -  -  - Diptera<br> -  -  -  - Culicidae<br> -  -  -  -  - <i>Aedes</i><br> -  -  -  -  -  - <i>Aedes albopictus</i><br> -  -  -  -  - <i>Anopheles</i><br> -  -  -  -  -  - [Anoph]<br> -  -  -  -  - <i>Armigeres</i><br> -  -  -  -  -  - [Armigeres]<br> -  -  -  -  - <i>Culex</i><br> -  -  -  -  -  - [Culex1]<br> -  -  -  -  -  - [Culex2]<br> -  -  -  -  -  - [Culex3]<br> -  -  -  -  -  - [CulexOP]<br> -  -  -  -  - [Species7]<br> -  -  -  -  - [Species8]<br> -  -  -  -  - [Species9]<br> -  -  -  -  - <i>Uranotaenia</i><br> -  -  -  -  -  - [Urano1]<br> -  -  -  -  -  - [Urano2]<br> -  -  -  -  - <i>Zeugnomyia</i><br> -  -  -  -  -  - <i>Zeugnomyia gracilis</i><br></div><p></p>
Illness perception mediates the relationship between the severity of symptoms and perceived health status in patients with Behcet's disease.
<p><strong>Abstract</strong></p> <p><em>Objective</em>. To investigate the relationship between psychological representations of illness, perceived health status and self-assessment of symptom severity in patients with <strong>Behçet's</strong>Disease – a rare long-term incurable condition with unclear etiology.</p> <p><em>Methods</em>. Using cross-sectional survey design, data on self-administered questionnaires on illness perception, health status, symptoms severity and demographic characteristics were collected from 273 patients with <strong>Behçet's</strong>Disease (age range 18 – 65+). The data were subjected to mediation analysis to test whether cognitive and emotional components of illness perception mediate the relationship between the severity of symptoms and heath status.</p> <p><em>Results</em>. The results support our hypotheses that cognitive components of illness perception (perceived consequences and identity of the illness) mediate the link between symptom activity and pain, whereas emotional components of the illness (emotional representations about the illness) mediate the relationship between disease activity and perceived energy level.</p> <p> <em>Conclusion</em>. The robustness of these mediation effects suggests potential directions for clinical psychologists and health care practitioners in developing support programmes. We supplement our study with Open Access database containing information about type of medication, comorbid mood disorder, detailed measurement of the severity of BD symptomsfor sharing and accumulating multidisciplinary knowledge aiming to support the development of interventions. Addressing psychological aspects ofBD will help to manage complex patients effectively.</p> <p>Database of survey (complete)</p>
Preprocessing scripts and data for study: Pathway-Based Subnetworks Enable Cross-Disease Biomarker Discovery
<p>Supplementary File 1 containing preprocessing scripts and data for converting pathway databases into subnetworks.</p>
[Supp. mat.] Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: initial application to the GENFI cohort
<p>Supplementary tables and figure of paper Spatio-temporal analysis for detection of pre-symptomatic shape changes in neuro-degenerative diseases: initial application to the GENFI cohort, for testing different number of clusters of the spatio-temporal regression. The supplementary materials shows results for 2 4 6 8 12 14 and 16 clusters. The 10 clusters analysis is in the paper.</p>
Bridging the Chromosome-Centric and Biology and Disease Human Proteome Projects: Accessible and automated tools for interpreting biological and pathological impact of protein sequence variants detected via proteogenomics
<p>Bridging the Chromosome-Centric and Biology and Disease Human Proteome Projects: Accessible and automated tools for interpreting biological and pathological impact of protein sequence variants detected via proteogenomics</p>
Synoptic table for surveillance scenarios for lumpy skin disease
<p>The Standing Group of Experts on lumpy skin disease (LSD) for South-East Europe under the GF-TADs umbrella recommended that all countries in South-East Europe, affected or at risk for LSD, should collaborate within the GF-TADs to draft a regional roadmap on an LSD exit strategy from 2018 onwards. This recommendation has triggered a mandate to EFSA in which it is asked to assess the effectiveness of different surveillance systems with different objectives, i.e. early detection or demonstration of freedom from disease, in the following contexts:</p> <p>(a) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and LSD vaccination was never carried out;</p> <p>(b) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and where LSD vaccination is carried out;</p> <p>(c) in areas where no LSD outbreaks have occurred and LSD preventive vaccination was carried out, and then stopped;</p> <p>(d) in areas where LSD outbreaks have been confirmed, and vaccination is stopped.</p> <p>For planning surveillance several elements should be considered: the objectives and related design prevalence, the epidemiological situation, the immunological status of the host population, the geographical area and the season, the type of surveillance (active or passive), the diagnostic methods including clinical detection (considered the most effective method for early detection of LSD), the target population, the sample size and frequency. Here a synoptic table is presented where each of these elements are discussed for each of the four scenarios given above.</p>
Synoptic table for surveillance scenarios for lumpy skin disease
<p>The Standing Group of Experts on lumpy skin disease (LSD) for South-East Europe under the GF-TADs umbrella recommended that all countries in South-East Europe, affected or at risk for LSD, should collaborate within the GF-TADs to draft a regional roadmap on an LSD exit strategy from 2018 onwards. This recommendation has triggered a mandate to EFSA in which it is asked to assess the effectiveness of different surveillance systems with different objectives, i.e. early detection or demonstration of freedom from disease, in the following contexts:</p> <p>(a) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and LSD vaccination was never carried out;</p> <p>(b) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and where LSD vaccination is carried out;</p> <p>(c) in areas where no LSD outbreaks have occurred and LSD preventive vaccination was carried out, and then stopped;</p> <p>(d) in areas where LSD outbreaks have been confirmed, and vaccination is stopped.</p> <p>For planning surveillance several elements should be considered: the objectives and related design prevalence, the epidemiological situation, the immunological status of the host population, the geographical area and the season, the type of surveillance (active or passive), the diagnostic methods including clinical detection (considered the most effective method for early detection of LSD), the target population, the sample size and frequency. Here a synoptic table is presented where each of these elements are discussed for each of the four scenarios given above.</p>
neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in early stage breast cancer as predictor of disease free survival
<p>The relationship between neutrophil-lymphocyte ratio (NLR) and outcome probably a complex and multifactorial issues. High neutrophil-lymphocyte ratio (NLR) is reflect the role of systemic inflammation in accelerate angiogenesis, tumor grow-up, and metastasis development.</p> <p><strong>Objective:</strong> The study aimed to estimate the relation between NLR, and PLR with disease free survival (DFS), and assess the values of clinico-pathologic factors on the prognosis.</p> <p><strong>Methods: </strong>Retrospectively we reviewed 1167 files and 102 patients with breast cancer included in Babylon Oncology Center from January 2009 to September 2014, and follow up for at least 36 months.</p> <p><strong>Results: </strong>102 patients, with mean age of 50.4 ± 11.7 years and minimum follow up 40 months, the overall median DFS was 62 months with 5 – years DFS of 52.5%, stage N0 show significant better DFS compared to stage N1 (P value 0.004), also patients with positive hormonal status show significant better DFS compared to negative hormonal status. The isolated local recurrence is 15% while combined local recurrences and distant metastasis is 37%.</p> <p><strong>Conclusion: </strong>NLR is a prognostic marker, and its establish the prediction models warrants further investigation. Increase NLR is strongly associated with poor DFS, and it can be as a predictive and prognostic factor.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.